You are visiting a website that is not intended for your region

The page or information you have requested is intended for an audience outside the United States. By continuing to browse you confirm that you are a non-US resident requesting access to this page or information.

Switch to the US site

Select Your Country or Region
Send
Covid-19 & PiCCO

Fighting Covid-19 with the help of Advanced Hemodynamic Monitoring

See how Prof. Grasso, from University Hospital di Bari in Italy, fought against a new virus and unknown disease in the midst of one of the worst Corona outbreaks in March 2020 in Italy.

Topics

 

The Italian experience: a practical advice

The Covid-19 Virus conquered the world within weeks, which overcrowded hospitals, and confronted intensive care physicians with a major challenge. Italy was affected quite heavily due to the unknown virus. Until the end of March 2020, 31.776 patients were hospitalized of which 3.981 were admitted to intensive care. [1] Therapeutic conflicts and an elderly population led to high death rates. 

 

Watch the interview with Prof. Grasso below. 

 

Fight an unknown enemy

Professor Salvatore Grasso, Head of the Department of Anesthesia and Resuscitation at the Faculty of Medicine and Surgery of the University of Bari Aldo Moro Polyclinic, tells his story about the worst health care situation in Italy. 

Watch the video and learn what he experienced firsthand during the treatment of severely ill patients, at this time, infected by an unknown virus. Prof. Grasso explains how he and his team managed the situation, what they learned about the virus and treatment of Covid-19 patients, and how the PiCCO technology and its parameters contributed to Professor Grasso's fight against the pandemic.

Related articles

  • Intensive Care

Mitigating the risk of harm during the transition from controlled to assisted mechanical ventilation

Monitoring the strength of the patient's breathing effort, titrating the sedation, and selecting the correct mode of ventilation is vital when transitioning from controlled to assisted ventilation.

Les mer

  • Intensive Care

Hemodynamic Management in Sepsis Patients

Everyone is at risk of developing sepsis. Globally, up to 50 million people are affected by sepsis, every year. Every 2.8 seconds, one patient dies from sepsis and associated complications. Often, it can be prevented by vaccination, clean water and hygiene, safe childbirth, and preventing hospital-acquired infections (HAIs). However, sepsis is often underdiagnosed, especially at an early stage where treatments are more successful.

Les mer

  • Intensive Care

Monitor diaphragm and improve mechanical ventilation

Respiratory support is a lifesaving intervention in the ICU, but without the right balance it also increases the risk of detrimental outcomes.1,2 This is when diaphragm monitoring can help, because it is a marker of outcomes such as hospital mortality and prolonged weaning. Furthermore, it can help you make more informed therapy decisions throughout respiratory treatment.

Les mer

  • Intensive Care

"Without access to an Edi signal you can’t give patients the best possible respiratory care."

Using the electrical activity of the diaphragm (Edi) to evaluate ICU patients’ need for respiratory support is a valuable and often superior complement to standard monitoring parameter, according to senior respiratory consultant Sten Borgström.

Les mer

  • Intensive Care

Low sedation ventilation strategy

The key to having less sedated and actively participating patients is to be able to meet their breathing needs. To try and sustain their natural breathing effort as much as possible.

Les mer

  • Intensive Care

ARDS

Acute respiratory distress syndrome (ARDS) is a serious lung condition that causes low blood oxygen. The incidence of ARDS varies widely.

Les mer

Alle referanser

  1. Megna, R. First month of the epidemic caused by COVID-19 in Italy: current status and real-time outbreak development forecast. glob health res policy 5, 43 (2020). https://doi.org/10.1186/s41256-020-00170-3